ストックスクリーナーアプリを入手
0.536
0.75%
0.004
アフターアワーズ：
.53
-0.006
-1.12%
前日終値:
$0.532
開ける：
$0.5376
24時間の取引高:
22,293
Relative Volume:
0.04
時価総額：
$728.62K
収益：
$75,000
当期純損益:
$-39.09M
株価収益率:
-0.00189
EPS:
-283.7191
ネットキャッシュフロー:
$-11.45M
1週間 パフォーマンス:
-29.47%
1か月 パフォーマンス:
-57.46%
6か月 パフォーマンス:
-97.63%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$0.51
$0.5376
1週間の範囲:
$0.4101
$0.76
52週間の値動き範囲:
$0.4101
$166.50
Profusa Inc Stock (PFSA) Company Profile
Compare PFSA vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PFSA
Profusa Inc
|
0.536 | 723.19K | 75,000 | -39.09M | -11.45M | -283.72 |
ABT
Abbott Laboratories
|
104.83 | 180.82B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
327.65 | 125.72B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
87.89 | 111.16B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
69.78 | 101.28B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
82.67 | 47.45B | 6.07B | 1.06B | 1.34B | 1.8063 |
Profusa Inc (PFSA) 最新ニュース
Profusa outlines revenue plan, targets EU commercial launch of Lumee in early Q2 2026 - MSN
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Profusa (PFSA) Stock Forecast and Price Target 2026 - MarketBeat
NVACW Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Profusa to liquidate Bitcoin holdings and faces Nasdaq delisting process By Investing.com - Investing.com Canada
According to the latest filing submitted to the U.S. Securities and Exchange Commission (SEC), biosensor technology company Profusa Inc has officially decided to terminate its Bitcoin treasury reserve strategy. - Bitget
Profusa terminates Bitcoin Treasury Reserve Strategy and to liquidate Bitcoin holdings - marketscreener.com
Profusa to liquidate Bitcoin holdings and faces Nasdaq delisting process - Investing.com
Profusa to End Account Control Agreement With Ascent Partners as It Exits Bitcoin Strategy - TradingView
Profusa (NASDAQ: NVACW) warned on delisting as it ends Bitcoin reserve plan - Stock Titan
PFSA Should I Buy - Intellectia AI
Critical Survey: Profusa (PFSA) vs. Its Rivals - Defense World
Profusa (PFSA) & Its Peers Financial Contrast - Defense World
PFSA Earnings History & Surprises | EPS & Revenue Results | PROFUSA INC (NASDAQ:PFSA) - ChartMill
PFSA SEC FilingsProfusa Inc 10-K, 10-Q, 8-K Forms - Stock Titan
PFSA Financials: Income Statement, Balance Sheet & Cash Flow | Profusa Inc - Stock Titan
Profusa, Mayo Clinic to Advance Clinical Applications of Oxygen Monitoring Technologies - Medical Product Outsourcing
[POS AM] Profusa, Inc. SEC Filing - Stock Titan
Head-To-Head Comparison: Profusa (PFSA) versus Its Competitors - Defense World
PFSA Technical Analysis & Stock Price Forecast - Intellectia AI
Profusa cancels $15M public offering, plans smaller fundraise By Investing.com - Investing.com Canada
Profusa cancels $15M public offering, plans smaller fundraise - Investing.com South Africa
Profusa To Withdraw S-1 Registration Statement to Pursue a Smaller, More Focused Offering - GlobeNewswire
Biosensor technology company Profusa Inc announced that revenue from its Lumee oxygen monitoring product in the European market is expected to receive substantial support starting from the second quarter of 2026. - Bitget
Profusa’s Market Moves as Revenue Reports Spark Uncertainty - StocksToTrade
Profusa Inc. Stock Declines Amid Financial Struggles and Market Uncertainty - timothysykes.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Profusa (PFSA) vs. Its Competitors Head-To-Head Review - Defense World
Analyzing Profusa (PFSA) and The Competition - Defense World
CapsoVision (NASDAQ:CV) and Profusa (NASDAQ:PFSA) Head-To-Head Review - Defense World
Contrasting Profusa (PFSA) & Its Rivals - Defense World
Contrasting Profusa (PFSA) & Its Peers - Defense World
Profusa raises 2026 revenue forecast on European purchase orders By Investing.com - Investing.com South Africa
Profusa raises 2026 revenue forecast on European purchase orders - Investing.com Nigeria
Profusa Raises 2026 Revenue Guidance to $3 Million Amid Strong Demand - Intellectia AI
Profusa Receives Purchase Orders for Lumee™ Tissue Oxygen Monitoring and Raises 2026 Revenue Guidance - The Manila Times
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Profusa (PFSA) and Its Rivals Head to Head Analysis - Defense World
Contrasting Profusa (PFSA) & Its Competitors - Defense World
Profusa (PFSA) & Its Peers Head-To-Head Review - Defense World
Head to Head Contrast: Profusa (NASDAQ:PFSA) versus Biosig Technologies (NASDAQ:STEX) - Defense World
Profusa announces initial $1 million bitcoin investment to initiate its digital asset treasury strategy - MSN
Comparing Profusa (PFSA) and Its Rivals - Defense World
Profusa, Mayo Clinic Partner on Oxygen Monitoring License - TipRanks
Profusa and Mayo Clinic collaborate to advance high-impact clinical applications of oxygen monitoring technologies - marketscreener.com
Profusa and Mayo Clinic collaborate to Advance High-Impact Clinical Applications of Oxygen Monitoring Technologies - The Manila Times
Mayo Clinic, Profusa explore continuous oxygen monitor for surgery - Stock Titan
Profusa Shares Fall 27% Following 1-for-75 Reverse Stock Split Becoming Effective - Nasdaq
Profusa Executes Significant 1-for-75 Reverse Stock Split - TipRanks
Profusa to shrink share count from 92.4M to 1.2M in reverse split - Stock Titan
Profusa Inc (PFSA) 財務データ
収益
当期純利益
現金流量
EPS
1.53%
大文字化:
|
ボリューム (24 時間):